Emergent BioSolutions Inc.EBSNYSE
Loading
EBITDA Over TimeStable
Percentile Rank79
3Y CAGR+134.2%
5Y CAGR-19.8%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+134.2%/yr
vs -43.6%/yr prior
5Y CAGR
-19.8%/yr
Recent acceleration
Acceleration
+177.8pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$201.80M+277.9%
2024$53.40M+213.6%
2023$-47.00M-399.4%
2022$15.70M-96.9%
2021$504.20M-17.2%
2020$609.20M+135.3%
2019$258.90M+66.9%
2018$155.10M-11.2%
2017$174.70M+31.5%
2016$132.90M-